Medtronic today announced primary endpoint (3-month) results of the Vectors Post Market Clinical Study that demonstrated effective pain relief and improved function in patients with chronic intractable back and leg pain treated with spinal cord stimulation [...]
According to CPT, both an Evaluation and Management (E/M) service and a procedure code can be reported if the patient's condition requires a significant, separately identifiable E/M service. "Significant" implies that the E/M service required [...]
According to CPT, both an Evaluation and Management (E/M) service and a procedure code can be reported if the patient's condition requires a significant, separately identifiable E/M service. "Significant" implies that the E/M service required [...]
According to CPT, both an Evaluation and Management (E/M) service and a procedure code can be reported if the patient's condition requires a significant, separately identifiable E/M service. "Significant" implies that the E/M service required [...]
Sagent Pharmaceuticals, announced the voluntary nationwide recall of Lot Number M813513 of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL). This product was manufactured by Zydus (Cadila Healthcare Limited) and distributed by Sagent Pharmaceuticals, Inc. [...]
Place your order for the Academy's latest textbook publication, Acute Pain Medicine, which covers the diagnosis and treatment of acute pain from both surgical and non-surgical causes. Pain syndromes are reviewed in a case-based format, [...]
Earlier this year, a consensus panel report addressing the challenges of implementing the CDC Guideline for Prescribing Opioids for Chronic Pain was published in Pain Medicine. The report, authored by a multidisciplinary panel convened by [...]
Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h Fentanyl Transdermal System patches contained 50 mcg/h patches. [...]
AAPM President Tim Lamer, MD contributed to this HealthyWomen article about the benefits of multidisciplinary chronic pain treatment, saying "It's more of a patient-centered, goal-oriented, holistic approach."Full story.
In research published online April 8 in the Journal of Neuroscience, the calcitonin gene-related peptide (CGRP) is implicated in the development of migraine symptoms caused pain responses in female rodents, but not in males, when [...]
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources | Powered by Insight Marketing Group
American Academy of Pain Medicine (AAPM) is a nonprofit, 501(c)(6) tax-exempt organization.
